Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Febuxostat × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 60 Carboplatin 57 Pemetrexed 47 Cisplatin 36 Paclitaxel 28 Specimen Handling 26 Nivolumab 24 durvalumab 22 osimertinib 21 Magnetic Resonance Spectroscopy 20 Docetaxel 20 Gemcitabine 13 atezolizumab 12 amivantamab 12 Radiotherapy 11 Ipilimumab 11 cemiplimab 10 Cetuximab 10 Drug Therapy 9 130-nm albumin-bound paclitaxel 9 Radiosurgery 8 lazertinib 7 Taxes 7 Bevacizumab 7 Radiation 6 Observation 6 sotorasib 5 alectinib 5 adagrasib 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07485452 2026-03-20

OSIBBBOOST

Maastricht University Medical Center

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡